T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$5.14B |
| 2 |
JPMorgan Chase
JPM
|
+$2.05B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
NVIDIA
NVDA
|
+$1.97B |
| 5 |
Apple
AAPL
|
+$1.73B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$2.74B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.74B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.9B |
| 5 |
Hilton Worldwide
HLT
|
+$1.79B |
Sector Composition
| 1 | Technology | 26.88% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.14% |
| 4 | Financials | 10.69% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
The ONE Group
STKS
$82.3M
| $117K | ﹤0.01% |
+11,153
| New | +$117K |
|
2802
Cullinan Oncology
CGEM
$392M
| $116K | ﹤0.01% |
11,127
+500
| +5% | +$5.21K |
|
2803
Quad
QUAD
$329M
| $116K | ﹤0.01% |
16,700
| – | – |
|
2804
MediciNova
MNOV
$62.8M
| $115K | ﹤0.01% |
43,100
+11,600
| +37% | +$31K |
|
2805
MiMedx Group
MDXG
$1.02B
| $114K | ﹤0.01% |
24,235
+2,482
| +11% | +$11.7K |
|
2806
SELLAS Life Sciences
SLS
$198M
| $114K | ﹤0.01% |
17,100
| – | – |
|
2807
SFL Corp
SFL
$1.09B
| $113K | ﹤0.01% |
+11,074
| New | +$113K |
|
|
SUNW
2808
DELISTED
Sunworks, Inc.
SUNW
| $112K | ﹤0.01% |
44,600
| – | – |
|
|
MTEM
2809
DELISTED
Molecular Templates, Inc.
MTEM
| $111K | ﹤0.01% |
2,144
+80
| +4% | +$4.14K |
|
2810
VistaGen Therapeutics
VTGN
$109M
| $110K | ﹤0.01% |
2,946
+134
| +5% | +$5K |
|
|
AMPE
2811
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $107K | ﹤0.01% |
757
+171
| +29% | +$24.2K |
|
2812
ClearPoint Neuro
CLPT
$305M
| $106K | ﹤0.01% |
+10,192
| New | +$106K |
|
2813
Citizens
CIA
$269M
| $105K | ﹤0.01% |
24,785
+1,100
| +5% | +$4.66K |
|
2814
PEDEVCO
PED
$54.2M
| $105K | ﹤0.01% |
78,100
| – | – |
|
|
MRNS
2815
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $105K | ﹤0.01% |
+11,183
| New | +$105K |
|
|
AERI
2816
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $105K | ﹤0.01% |
11,512
-1,892
| -14% | -$17.3K |
|
2817
American Axle
AXL
$704M
| $104K | ﹤0.01% |
+13,412
| New | +$104K |
|
|
CKPT
2818
DELISTED
Checkpoint Therapeutics
CKPT
| $104K | ﹤0.01% |
+5,900
| New | +$104K |
|
2819
Harrow
HROW
$1.48B
| $103K | ﹤0.01% |
15,100
| – | – |
|
2820
Yext
YEXT
$1.05B
| $102K | ﹤0.01% |
14,846
+3,272
| +28% | +$22.5K |
|
|
TCRR
2821
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $102K | ﹤0.01% |
36,781
+500
| +1% | +$1.39K |
|
|
PZN
2822
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $100K | ﹤0.01% |
12,439
+300
| +2% | +$2.41K |
|
|
REV
2823
DELISTED
Revlon, Inc.
REV
| $100K | ﹤0.01% |
+12,366
| New | +$100K |
|
|
BLUE
2824
DELISTED
bluebird bio
BLUE
| $100K | ﹤0.01% |
1,034
+75
| +8% | +$7.25K |
|
|
SCPX
2825
DELISTED
Scorpius Holdings, Inc.
SCPX
| $100K | ﹤0.01% |
8
| – | – |
|